ASEAN’s Leading Radiopharmaceutical Company
Supporting Future Radiopharmaceutical Capability in Indonesia
Cyclotek is engaging with partners to explore how specialist radiopharmaceutical manufacturing, development and clinical trial support could contribute to future capability in Indonesia. Our approach is collaborative and locally respectful, focused on understanding partner needs and supporting sustainable access over time.
About Us
Partnership-Led Regional Growth
Cyclotek brings experience across radiopharmaceutical manufacturing, clinical supply, CDMO support and research translation in Australia and New Zealand. In selected international markets, our approach is to work with local partners, respect local regulatory pathways and support sustainable capability development over time.
Established ANZ radiopharmaceutical manufacturing network
Supporting 200,000+ patient doses annually across Australia and New Zealand
Clinical, research and CDMO capability
Partnership-led regional growth
About Us
A large and diverse healthcare market
Indonesia is a large and geographically diverse healthcare market where access, infrastructure and local partnerships are central to any long-term capability pathway. Cyclotek recognises the importance of working with local organisations to explore how radiopharmaceutical expertise can support clinical research, advanced diagnostics and future patient access in a way that is practical, sustainable and locally led.
Our experienced team works collaboratively with hospitals, researchers and industry partners to deliver innovative radiopharmaceutical solutions that improve diagnosis, treatment and patient outcome.
Products & Services
Capabilities that can support future access
Subject to local regulatory requirements and partnership models, Cyclotek can bring experience across radiopharmaceutical manufacturing, clinical trial support, technology transfer and time-critical supply chain planning.
Product Supply & Logistics
Reliable radiopharmaceutical manufacturing and supply supporting clinical imaging and patient care across Australia and New Zealand.
Contract Manufacturing
Advanced TGA and GMP licensed manufacturing facilities supporting commercial production, research and clinical trial supply.
Local Collaboration
Exploring practical pathways with local partners
Cyclotek is exploring opportunities to work alongside local partners to support the future of radiopharmaceuticals in Indonesia. Through ongoing collaboration, we seek to identify practical pathways that align with local clinical needs, regulatory requirements and operational environments.
Partnership & Research
Building capability through trusted collaboration
Speak with Cyclotek about partnership opportunities, clinical trial support, CDMO capability or future radiopharmaceutical access in Indonesia.
Partner with Cyclotek
Cyclotek works with healthcare providers, universities, research organisations and pharmaceutical partners to explore pathways that can connect scientific development with reliable manufacturing and patient access.
Insights & Updates
Insights, Research & Industry Updates
National University of Singapore (NUS) Yong Loo Lin School of Medicine – Clinical Imaging Research Centre (CIRC) and Cyclotek Announce Strategic Collaboration to Strengthen Radiopharmaceutical Capability in Singapore and Across ASEAN
Learn More
Showing 3 / 50